See this page online at: http://www.biotechfocus.com/2010Issue10
 |
Sign up for your subscription and keep up-to-date.
Stay updated on the latest news and technologies with Bioscienceworld's newsletters.
Five to choose from.
|
Biomedical Powerhouse How the Samuel Lunenfeld
By Karin Fleming
Starting and maintaining a successful biomedical research institute is just like science itself: an experiment. |
|
Even Bigger Pharma? What's Next?
By John Lawson and Pierre Bourassa
From there being over 500 companies doing international pharmaceutical business in 1970, there were only 49 in 2008 and the term Big Pharma (with sales of more than $10 billion) can only be applied to 19 of them. |
|
NeurAxon Inc. offering more than just pain relief
By Tim Bryant
It’s a given a biotech company needs money to get off the ground and be successful. What isn’t a given is how much is needed to make that happen. In the case of Toronto-based NeurAxon Inc., it is abundantly clear the lack of a multi-billion dollar research budget has not hindered its success. |
|
Genome Canada gets a new general Former Genome BC chief scientific officer to head Genome Canada
By Shawn Lawrence
It’s hard to believe that ten years have passed since the development of genomics as a significant science led the government of Canada to set up Genome Canada. |
|
Toronto to host Inaugural Tech Transfer Summit
Compiled By Shawn Lawrence
The inaugural Tech Transfer Summit North America is set to take place in Toronto November 22-23, marking the first time the event held previously in Europe and Russia, has come to North America. |
|
Biotech Entrepreneurship, Start-Ups and Hollywood
By Robert Foldes
I recently saw the movie Extreme Measures starring Brendan Fraser and Harrison Ford. |
